Impact of Neoadjuvant Chemoradiotherapy on Health Related Quality of Life In Long-Term Survivors of Esophageal or Junctional Cancer: Results from the Randomized Cross Trial

A new study is out on quality-of-life measures for survivors who received neoadjuvant therapy versus surgery, suggesting that neoadjuvant chemoradiotherapy can be considered as a standard of care.